Axactor (ACR) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
29 Oct, 2026Executive summary
Q3 gross revenue was EUR 74.3m, down 5% YoY reported and 3% excluding Q4'25 divestments.
Collection performance reached 104%, versus 98% YoY, in line with expectations and driven by secured portfolios.
ACR04 refinancing at a tighter margin and lower debt reduced external-loan interest expense YoY and QoQ.
Financial highlights
Total revenue was EUR 56.9m versus EUR 61.7m in Q3 2025.
EBITDA was EUR 26.2m versus EUR 32.6m, with a 46% margin; cash EBITDA was EUR 43.9m versus EUR 49.4m.
EBIT was EUR 24.1m versus EUR 30.7m; net profit was EUR 2.9m versus EUR 9.6m, and EPS was EUR 0.001 versus EUR 0.032.
External-loan interest expense fell 17% YoY and 19% QoQ; Q4 expense was expected at EUR 12m, assuming a EUR 235m RCF draw and other stated conditions.
Operating cash flow including NPL investments was EUR 73.3m versus EUR 36.7m; cash flow before NPL investments was EUR 92.8m versus EUR 39.1m.
Outlook and guidance
FY 2026 NPL investment range is EUR 100–150m; the annual target from 2027 is EUR 200–400m, subject to return requirements and portfolio availability.
Targets from 2027 include external servicing revenue growth of 10% annually, ROE above 15%, and net debt / cash EBITDA leverage of 2.25–2.75x.
Target distribution is at least 50% of adjusted net profit through dividends and/or buybacks; first shareholder distribution is targeted for June 2027, subject to stated assumptions.
Q4 is typically the busiest acquisition period, with a healthy pipeline; investment volumes depend on portfolio wins and attractive risk-return.
Priorities include scaling co-investments, winning 3PC contracts, refinancing ACR05 in June 2027, and improving efficiency through automation and AI.
Latest events from Axactor
- Major equity raise and NPL revaluation drive net loss, but leverage and 3PC growth improve.ACR
Q2 2026 - Double-digit growth, improved ROE, and tech-driven efficiency amid regulatory shifts.ACR
Status update - Major equity and bond deals cut funding costs and set new growth targets amid revenue decline.ACR
Q1 2026 - EUR 200m placement and co-investment deal to drive growth, boost capacity, and reduce leverage.ACR
Investor update - Revenue and margins improved, with strong 3PC growth and focus on deleveraging over dividends.ACR
Q4 2025 - Cash EBITDA up 6% to EUR 59M, but net profit and ROE to shareholders fell to 0%.ACR
Q3 2024 - Cash EBITDA up 3% to EUR 61.1M as cost control offsets 2% revenue decline.ACR
Q2 2024 - Record 12% ROE, 50% EBITDA margin, and 28% 3PC growth highlight strong Q1 results.ACR
Q1 2025 - Q4 revenue surged on a Spanish sale, but negative revaluations led to a net loss; liquidity is strong.ACR
Q4 2024